Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

<h4>Background</h4> <p>EXSCEL is a randomized, double-blind, placebo-controlled trial examining the effect of exenatide once-weekly (EQW) versus placebo on time to the primary composite outcome (cardiovascular death, nonfatal myocardial infarction or nonfatal stroke) in patients w...

Full description

Bibliographic Details
Main Authors:	Mentz, R, Bethel, M, Gustavson, S, Thompson, V, Pagidipati, N, Buse, J, Chan, J, Iqbal, N, Maggioni, A, Marso, S, Ohman, P, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, A, Holman, R
Format:	Journal article
Language:	English
Published:	Elsevier 2017

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

Similar Items